Baxter International | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Abbott USD 49.06B 9.04B 2025-03
AtriCure USD 454.62M 6.35M 2025-03
Avanos Medical USD 828.5M 401.2M 2024-12
Baxter International USD 6.96B 908M 2024-12
Becton, Dickinson and Co. USD 25.2B 685M 2024-12
Boston Scientific USD 21.77B 1.06B 2024-12
Cooper Companies USD 8.13B 44.1M 2025-01
Dexcom USD 2.1B 123.6M 2024-12
Edwards Lifesciences USD 10B 452.8M 2024-12
Fresenius EUR 19.54B 715M 2024-12
Globus Medical USD 4.18B 107.94M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
ICU Medical USD 1.97B 83.35M 2024-12
Insulet USD 1.21B 93.6M 2024-12
Integra LifeSciences USD 1.55B 23.69M 2024-12
Intuitive Surgical USD 17.21B 678.1M 2025-03
J&J USD 78.11B 6.62B 2025-03
Laboratory Of America USD 8.32B 269.5M 2025-03
Masimo USD 1.05B 411.3M 2024-12
Medtronic USD 49.39B 893M 2025-01
Merit Medical Systems USD 1.43B 49.06M 2025-03
Quest Diagnostics USD 6.93B 151M 2025-03
Smith & Nephew USD 5.26B 60M 2024-12
Stryker USD 20.63B 485M 2024-12
Tandem Diabetes Care USD 155.29M 107.81M 2025-03
Teleflex USD 4.1B 182.98M 2025-03
Terumo JPY 1.4T 90.06B 2024-12
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12



Baxter International Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.